| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -1.4e-06 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.05 | 0.4 |